Association of Symptoms and Collaborative Care Intervention (TĀCcare) with Systemic Inflammation Biomarkers in End-Stage Kidney Disease.
Cramer J KallemAlaa A AlghwiriJonathan G YabesMaria-Eleni RoumeliotiSarah J EricksonBruce L RollmanSteven WeisbordMark UnruhYoram VodovotzManisha JhambJennifer L SteelPublished in: Kidney360 (2024)
The TĀCcare intervention had a short-term impact on reducing inflammatory burden in patients with ESKD. More studies are needed to confirm our findings and to determine if these biomarkers mediate the link between symptoms and disease progression.